Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Alantra’s UK advisory business announces promotions

Alantra today announced the promotion of two members of its UK advisory business (formerly Catalyst Corporate Finance): Tom Cowap and Ali Robertson have both been promoted to Director.

Tom Cowap joined Catalyst in 2013 and is a key member of the Healthcare team where he focuses on Pharma, Life Sciences and Pharma Services. He has advised on significant deals in this sector including the acquisition of Concept Life Sciences, as well as the sales of CP Electronics and Interfloor and private equity transactions at Make it Cheaper and XLN Business Services. He is also one of the authors of the annual Alantra Pharma Fast 50.

Ali Robertson joined the Industrials team in 2013 where he focuses on Chemicals and Coatings, and more recently on the Specialty Materials and Marine sectors. Key deals on which he has advised include the sales of Expert Tooling, Raphael Healthcare, ATG and Morrells, as well as the buy-out of  Westleigh Homes. Ali is also one of the authors of Alantra’s annual Chemical & Coatings Fast 25 ranking.

These promotions come shortly after Catalyst Corporate Finance rebranded as Alantra, with its partners leading Alantra’s UK advisory business.  Catalyst announced its merger with Alantra, the global investment banking and asset management firm, in October 2017 with the goal of creating a leading global advisory business in the mid-market.

Andy Currie, Managing Partner, commented: “Many congratulations to both Tom and Ali on their well-deserved promotions.  As a business, our goal is to provide clients with the very best sector-focused advice on a global basis, and both Ali and Tom have made very tangible contributions to our industrials and healthcare teams in the UK. One of the most exciting features of our merger with Alantra is the great opportunity for our people, who will benefit from being part of a leading international business and working collaboratively with like minded colleagues from across the globe.  I have every confidence that Tom and Ali will enjoy continued success as Directors within the Alantra international partnership.”

During the last six months, Alantra’s advisory teams have completed over 70 deals for a total value of more than £4.5bn, acting on behalf of private company shareholders, global corporations, private equity funds and other financial institutions,